Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Malaria Vaccines Market from 2024 to 2025?

The market size of malaria vaccines has seen exponential growth over the past few years. It is projected to increase from $4.7 billion in 2024 to $6.3 billion in 2025, suggestive of a compound annual growth rate (CAGR) of 34.0%. The remarkable growth during the historical period can be accredited to factors such as a high burden of malaria, worldwide health initiatives, financial assistance and grants, programs aimed at controlling malaria, the backup from government, and regulatory structures.

What Is the Projected Market Size of the Malaria Vaccines Market?

In the coming years, it’s anticipated that the malaria vaccines market will experience significant growth, with projections suggesting it will expand to a noteworthy $20.65 billion by 2029, reflecting a compound annual growth rate (CAGR) of 34.5%. Factors contributing to this optimistic growth forecast include global elimination objectives, a rise in vaccine accessibility programs, enhanced vaccine coverage, and global vaccine collaborations, coupled with the effects of climate change. The forecast period is also expected to witness several key trends which will further stimulate growth, such as technological breakthroughs in vaccine technology, the fostering of public-private partnerships, and increased international cooperation.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13698&type=smp

Who are the Major Competitors in the Malaria Vaccines Market Outlook?

Major companies operating in the malaria vaccines market report are Pfizer Inc., Ipca Laboratories Ltd., Novartis AG, Sanofi SA, GlaxoSmithKline Plc., Takeda Pharmaceutical Co Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Lupin, Taj Pharmaceuticals Limited., Nobelpharma Co. Ltd., Bliss GVS Pharma Ltd., Sanaria Inc., Precigen Inc., AdvaCare Pharma, CellFree Sciences, Actiza Pharmaceutical Private Limited, Sumaya Biotech, VLP Therapeutics LLC, GeoVax Labs Inc., Zydus Cadila, Genvec Inc.

What Is Fueling Growth in the Malaria Vaccines Market?

The upward trend in mosquito-borne illnesses is projected to fuel the expansion of the malaria vaccine market. These diseases encompass a cluster of conditions transmitted through the bite of an infected mosquito. The malaria vaccine, especially the RTS, S/AS01 (RTS, S) vaccine, is instrumental in mitigating the severity of mosquito-related infectious diseases by priming the immune system to identify and counteract the parasite. For example, the World Health Organization, a Switzerland-based international entity, revealed in a report in November 2023, that an approximated 249 million malaria cases occurred worldwide in 2022, marking a surge of 5 million cases from 2021. Additionally, in 2022, Pakistan documented around 2.6 million cases, a significant increase from the 500,000 reported in 2021. Thus, the increasing prevalence of mosquito-related diseases is propelling the growth of the malaria vaccine market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13698&type=smp

Which Malaria Vaccines Market Segments Are Growing the Fastest?

The malaria vaccines market covered in this report is segmented –

1) By Agent: Plasmodium Falciparum, Plasmodium Vivax, Anopheles Species

2) By Vaccine Type: Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines

3) By Route Of Administration: Intramuscular, Subcutaneous, Intradermal, Other Routes

4) By Distribution Channel: Public, Private

Subsegments:

1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine, Other Experimental Vaccines

2) By Plasmodium Vivax: Candidate Vaccines In Development, Combination Vaccines

3) By Anopheles Species: Transmission-Blocking Vaccines, Vector Control Approaches

Which Industry Trends Are Shaping the Future of the Malaria Vaccines Market?

Major businesses in the malaria vaccine market are inventing unique products like children’s malaria vaccines to expand their customer base, enhance sales, and boost revenue. These vaccines intended for mosquito-transmitted diseases are immunological compositions aimed at safeguarding from diseases spread by mosquitoes. They are primarily targeted at defending against Plasmodium falciparum, which is the deadliest global malaria parasite and predominantly found in Africa. In November 2022, Malawi, an East African nation, in conjunction with the World Health Organization, a Switzerland-situated intergovernmental body, initiated the first children’s malaria vaccine in Africa. The RTSS vaccine, created for young children, stands out due to its capacity to reduce death rates from the mosquito-spread disease. Despite having a modest effectiveness rate of only 30%, the vaccine has raised hopes based on its pilot test on more than a million children in Ghana, Kenya, and Malawi, as the vaccine could potentially save lives among the annual 400,000 malaria victims.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

Which Countries Are Leading the Malaria Vaccines Market?

North America was the largest region in the malaria vaccines market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the malaria vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13698

This Report Delivers Insight On:

1. How big is the malaria vaccines market, and how is it changing globally?

2. Who are the major companies in the malaria vaccines market, and how are they performing?

3. What are the key opportunities and risks in the malaria vaccines market right now?

4. Which products or customer segments are growing the most in the malaria vaccines market?

5. What factors are helping or slowing down the growth of the malaria vaccines market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model